Vivani Medical (VANI) announced the successful administration of its first GLP-1 or exenatide, implant in the LIBERATE-1 clinical trial. This ...

The Vivani Medical Inc. combination appears to be over less than three years since its inception after the company reported ...

Vivani Medical will spin off Cortigent, its neurostimulation business, as an independently publicly traded company as it looks to prioritise its portfolio of weight loss drug implants. While Vivani ...

The company wants to create two focused companies dedicated to driving current and future value in their respective ...

Vivani Medical (NASDAQ:VANI) said on Wednesday that it intends to divest its Cortigent unit, which builds neurostimulation ...

Vivani Medical (VANI) announced that it intends to spin off Cortigent, a division that develops brain implant devices to help people recover ...

OsteoStrong, the global leader in osteogenic loading technology, is hosting a live webinar featuring CEO Kyle Zagrodzky and biomedical engineer Dr. John Jaquish to discuss newly published research on ...

Physician Growth Partners ("PGP"), a leading healthcare investment banking and M&A Advisory firm, is pleased to announce it ...

Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing ...

Vivani Medical plans to spin off Cortigent into a separate public company, aiming to expand neurostimulation technology while ...